These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11938022)

  • 1. Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus.
    Sobngwi E; Mauvais-Jarvis F; Vexiau P; Mbanya JC; Gautier JF
    Diabetes Metab; 2002 Feb; 28(1):5-12. PubMed ID: 11938022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketosis-prone atypical diabetes mellitus: report of two cases].
    Belhadi L; Chadli A; Bennis L; Ghomari H; Farouqi A
    Ann Endocrinol (Paris); 2007 Dec; 68(6):470-4. PubMed ID: 17692810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.
    Mauvais-Jarvis F; Sobngwi E; Porcher R; Riveline JP; Kevorkian JP; Vaisse C; Charpentier G; Guillausseau PJ; Vexiau P; Gautier JF
    Diabetes; 2004 Mar; 53(3):645-53. PubMed ID: 14988248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in sub-Saharan Africa: implications for transitional populations.
    Osei K; Schuster DP; Amoah AG; Owusu SK
    J Cardiovasc Risk; 2003 Apr; 10(2):85-96. PubMed ID: 12668905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY; Ragoobirsingh D; Peter SA
    Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of diabetes mellitus: prevalence, incidence, pathogenesis, and prognosis].
    Janka HU; Michaelis D
    Z Arztl Fortbild Qualitatssich; 2002 Mar; 96(3):159-65. PubMed ID: 12017759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The burden of diabetes in Africa: a major public health problem].
    Jaffiol C
    Bull Acad Natl Med; 2011 Jun; 195(6):1239-53; discussion 1253-4. PubMed ID: 22530517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 11. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
    Linfoot P; Bergstrom C; Ipp E
    Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathological mechanisms in type 1 and type 2 diabetes].
    Boitard Ch
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():7-12. PubMed ID: 15666475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ketosis-prone type 2 diabetes mellitus in sub-Saharan Africans: possible contribution of human herpes virus 8 infection].
    Gautier JF
    Med Sci (Paris); 2008; 24(6-7):665-6. PubMed ID: 18601887
    [No Abstract]   [Full Text] [Related]  

  • 19. Time to insulin in type-2 diabetes: high hurdles or Santiago way?
    Rotella CM; Pala L
    Acta Diabetol; 2008 Jun; 45(2):67-74. PubMed ID: 18408882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.